Cullin-3 proteins be a novel biomarkers and therapeutic targets for hyperchloremia induced by oral poisoning.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 04 2024
Historique:
received: 19 11 2023
accepted: 08 04 2024
medline: 15 4 2024
pubmed: 14 4 2024
entrez: 13 4 2024
Statut: epublish

Résumé

Oral poisoning can trigger diverse physiological reactions, determined by the toxic substance involved. One such consequence is hyperchloremia, characterized by an elevated level of chloride in the blood and leads to kidney damage and impairing chloride ion regulation. Here, we conducted a comprehensive genome-wide analysis to investigate genes or proteins linked to hyperchloremia. Our analysis included functional enrichment, protein-protein interactions, gene expression, exploration of molecular pathways, and the identification of potential shared genetic factors contributing to the development of hyperchloremia. Functional enrichment analysis revealed that oral poisoning owing hyperchloremia is associated with 4 proteins e.g. Kelch-like protein 3, Serine/threonine-protein kinase WNK4, Serine/threonine-protein kinase WNK1 and Cullin-3. The protein-protein interaction network revealed Cullin-3 as an exceptional protein, displaying a maximum connection of 18 nodes. Insufficient data from transcriptomic analysis indicates that there are lack of information having direct associations between these proteins and human-related functions to oral poisoning, hyperchloremia, or metabolic acidosis. The metabolic pathway of Cullin-3 protein revealed that the derivative is Sulfonamide which play role in, increasing urine output, and metabolic acidosis resulted in hypertension. Based on molecular docking results analysis it found that Cullin-3 proteins has the lowest binding energies score and being suitable proteins. Moreover, no major variations were observed in unbound Cullin-3 and all three peptide bound complexes shows that all systems remain compact during 50 ns simulations. The results of our study revealed Cullin-3 proteins be a strong foundation for the development of potential drug targets or biomarker for future studies.

Identifiants

pubmed: 38615119
doi: 10.1038/s41598-024-59264-4
pii: 10.1038/s41598-024-59264-4
pmc: PMC11016057
doi:

Substances chimiques

Biomarkers 0
Chlorides 0
Cullin Proteins 0
Halogens 0
CUL3 protein, human 0
Protein Serine-Threonine Kinases EC 2.7.11.1
WNK1 protein, human EC 2.7.11.1
WNK4 protein, human EC 2.7.11.1
WNK Lysine-Deficient Protein Kinase 1 EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8597

Informations de copyright

© 2024. The Author(s).

Références

Oncology (Williston Park). 2013 Aug;27(8):798-803
pubmed: 24133829
Cureus. 2022 Feb 4;14(2):e21912
pubmed: 35273861
Biochem J. 2005 Oct 1;391(Pt 1):17-24
pubmed: 16083423
Intensive Care Med Exp. 2018 Apr 13;6(1):10
pubmed: 29654387
Nucleic Acids Res. 2013 Jan;41(Database issue):D377-86
pubmed: 23193289
Biochem J. 2013 Apr 1;451(1):111-22
pubmed: 23387299
J Urol. 2019 Mar;201(3):436-437
pubmed: 30759664
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Medicine (Baltimore). 2019 Feb;98(6):e14371
pubmed: 30732172
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Emerg (Tehran). 2018;6(1):e52
pubmed: 30584568
Proc Natl Acad Sci U S A. 2023 May 30;120(22):e2217425120
pubmed: 37216554
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7838-43
pubmed: 23576762
BMC Syst Biol. 2014;8 Suppl 4:S11
pubmed: 25521941
Redox Biol. 2013 Jul 16;1:366-72
pubmed: 24024173
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Nucleic Acids Res. 2021 Jan 8;49(D1):D1144-D1151
pubmed: 33237278
Biophys Rev. 2021 Mar 29;13(2):259-272
pubmed: 33936318
J Hum Genet. 2021 May;66(5):491-498
pubmed: 33130828
Neurotoxicology. 2014 Sep;44:27-38
pubmed: 24820435
Nefrologia. 2016 Jul-Aug;36(4):347-53
pubmed: 27267918
Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5
pubmed: 23193258
Nature. 2012 Jan 22;482(7383):98-102
pubmed: 22266938
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Pediatr Crit Care Med. 2018 Feb;19(2):155-160
pubmed: 29394222
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Hum Genomics. 2013 May 15;7:13
pubmed: 23676014
Nat Genet. 1996 Mar;12(3):248-53
pubmed: 8589714
F1000Res. 2017 Nov 1;6:1930
pubmed: 29123653
Crit Care Med. 2015 Sep;43(9):1938-44
pubmed: 26154934
Cell Commun Signal. 2023 Oct 16;21(1):286
pubmed: 37845702

Auteurs

Hui Duan (H)

Department of Emergency Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, China.

Na Li (N)

Department of Vascular Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, China.

Jia Qi (J)

Department of Hematology, Taihe Hospital, Hubei University of Medicine, Shiyan, China.

Xi Li (X)

Department of Ophthalmology, Taihe Hospital, Hubei University of Medicine, Shiyan, China.

Kun Zhou (K)

Department of Physical Examination Center, Taihe Hospital, Hubei University of Medicine, Shiyan, China. zhoukun@taihehospital.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH